Maternal prenatal stress has been linked to a variety of infant postnatal outcomes, partially through alterations in fetal HPA axis functioning; yet the underlying pathobiology remains elusive. Current literature posits DNA methylation as a candidate mechanism through which maternal prenatal stress can influence fetal HPA axis functioning. The goal of this systematic review was to summarize the literature examining the associations among maternal prenatal stress, DNA methylation of commonly studied HPA axis candidate genes, and infant HPA axis functioning. Results from the review provided evidence for a link between various maternal prenatal stressors, NR3C1 methylation, and infant stress reactivity, but findings among other genes were limited, with mixed results. An original study quality review tool revealed that a majority of studies in the review are adequate, and emphasizes the need for future research to consider study quality when interpreting research findings.
| INTRODUCTION
The impact of maternal stress during pregnancy on infant emotional, behavioral, and biological outcomes has been well documented (for a review, see Graignic-Philippe, Dayan, Chokron, Jacquet, & Tordjman, 2014) ; however, the potential mechanisms linking prenatal stress (e.g., psychosocial stress, trauma) to these outcomes are still under debate (Monk, Spicer, & Champagne, 2012) . In general, current theory posits that maternal stress during pregnancy affects fetal development through the placenta, which regulates the fetal environment and is highly susceptible to maternal stress (Barker, 1990; Bronson & Bale, 2015) . Specifically, stress experienced by the mother increases the risk for alterations of the fetus' hypothalamic-pituitary-adrenal (HPA) axis; these changes have been associated with a variety of negative postnatal outcomes (Moisiadis & Matthews, 2014) , but results are largely inconclusive (Beijers, Buitleaar, & de Weerth, 2014) . Nonetheless, recent theory and research suggests that DNA methylation (DNAm) is a potential epigenetic mechanism that may mediate the association between maternal prenatal stress and fetal HPA axis functioning, ultimately contributing to poor postnatal infant outcomes (e.g., Palma-Gudiel, Córdova-Palomera, Eixarch, Deuschle, & Fañanás, 2015) . Although research has primarily focused on one candidate gene implicated in HPA axis functioning (NR3C1; Palma-Gudiel et al., 2015; Turecki & Meaney, 2016) , it is reasonable to expect that the epigenetic modification of many other genes also can affect fetal HPA axis functioning. The goal of the current systematic review was to synthesize the clinical literature linking maternal prenatal stress to infant DNAm across a variety of HPA axis candidate genes, and subsequent infant stress reactivity. The ultimate goal is to better understand how DNAm patterns in genes related to HPA-axis functioning can elucidate the complex association between maternal prenatal stress and infant outcomes.
| Maternal prenatal stress and fetal development
Research examining the role of the intrauterine environment in fetal development and subsequent postnatal outcomes was largely influenced by a series of epidemiological studies carried out by David Barker late in the 20th century (for a review of these studies, see Barker, 2007) . It was Barker's group who discovered that low birth weight serves as a proxy for both fetal and adult health (e.g., Barker, Winter, Osmond, Mergetts, & Simmond, 1989) , and this work led to the development of Barker's fetal origins of adult disease (FOAD) hypothesis. Broadly, this hypothesis states that an adverse intrauterine environment can impact fetal and early postnatal development (e.g., low birth weight), which has lasting implications for adult health (Wadhwa, Buss, Entringer, & Swanson, 2009 ). Barker's work stimulated a great deal of interest in the idea of developmental plasticity, which posits that there are developmental periods whereby an organism is plastic (i.e., sensitive) to the environment (Calkins & Devaskar, 2011) . The FOAD hypothesis informed much research examining the link between prenatal stress and adult health (Calkins & Devaskar, 2011; Wadhwa et al., 2009 ) and led the development of the Developmental Origins of Health and Disease (DOHaD) approach (Gluckman, Hanson, & Bukijas, 2010) to studying the effects of early life stress on adult disease.
The DOHaD framework builds upon the FOAD approach in two main ways. First, the DOHaD approach places equal emphasis on the prenatal and early postnatal environments in contributing to adult disease, as both are sensitive periods of development. Second, the DOHaD approach emphasizes health promotion in addition to disease prevalence and prevention (Gluckman & Hanson, 2006) . This theoretic shift towards the DOHaD approach also has spurred a great deal of research aiming to identify the mechanisms through which early (e.g., prenatal) adversity embeds itself into an individual. The identification of these mechanisms advances our understanding of exactly how prenatal stress contributes to both short-and long-term postnatal outcomes. Epigenetic mechanisms have been proposed as one set of processes through which changes to the maternal environment can affect fetal development and postnatal functioning, ultimately contributing to adult disease. Broadly, epigenetics refers to the study of heritable changes to DNA that do not alter the DNA sequence itself (Conradt, 2017) . Prior to exploring the role of specific epigenetic mechanisms in prenatal stress and fetal development, it is necessary to understand why maternal prenatal stress is important to fetal and infant development.
Although much of the early work on the FOAD focused on undernutrition as a key prenatal stressor, subsequent research has explored how maternal psychosocial stressors have similar implications for the fetus throughout pregnancy (for a review, see Janssen et al., 2016) . Maternal prenatal stress has typically been conceptualized as including traumatic life events (e.g., physical or sexual assault; Kertes et al., 2016) , stressful situations or experiences (e.g., poverty, daily hassles; Dukal et al., 2015) , subsequent perceptions of these stressors (e.g., self-reports of perceived stress; Dukal et al., 2015) , and the phenotypes that result from stressors, such as anxiety or depression (e.g., Beijers et al., 2014; Oberlander et al., 2008) . The inclusion of depression and anxiety as a "stressor" has contributed to criticisms over definitions of stress in the literature (see Kagan, 2016 for a discussion on this issue); however, researchers have typically viewed these phenotypes as stressors since they have a negative effect on the mother (e.g., alterations in cortisol levels) that pose a threat to the fetus (e.g., O'Connor, Bergman, Sarkar, & Glover, 2013) .
In light of the issues surrounding the conceptualization of stress, understanding the effect of maternal psychosocial stress (and associated phenotypes) on fetal development is important for several reasons. First, the prenatal period is one of rapid neurological and physical development for the fetus, which is placed at an increased risk for maladaptation. Indeed, there are multiple lines of evidence suggesting that maternal psychosocial stress during pregnancy is linked to various negative birth outcomes, primarily low birth weight and premature birth (Graignic-Philippe et al., 2014) , but also social, emotional, and neurodevelopmental problems in childhood (Talge, Neal, & Glover, 2007) . Secondly, the fetus is unusually susceptible to the biological effects of maternal stress due to its attachment to the mother via the placenta. For example, Glover, Bergman, Sarkar, and O'Connor (2009) found that maternal levels of cortisol were moderately correlated with amniotic cortisol levels (r = 0.32), and that this correlation was even higher in a subsample of the most anxious mothers (r = 0.59), suggesting a link between maternal and fetal cortisol levels. Lastly, understanding the timing of stress during pregnancy is necessary to elucidate potentially sensitive periods of prenatal development. For example, the fetal HPA axis is not fully developed until the 2nd trimester, so the effect of stress on this system may not be visible unless the stressors occur later during pregnancy (Moisiadis & Matthews, 2014) . Conversely, evidence suggests that changes to gene expression and subsequent behavior can occur as early as the embryonic stage of human development (Crews, 2010) . Altogether, the evidence underscores the importance of the maternal environment for pre and postnatal development; however, the mechanism(s) through which maternal prenatal stress influences fetal and infant outcomes remains unclear.
| DNA methylation and gene expression
Recent theoretical and empirical inquires suggest that epigenetic processes provide, in part, an explanation for the link between maternal stress during pregnancy and various physiological and behavioral outcomes throughout the lifespan (for reviews, see CaoLei, Laplante, & King, 2016; Monk et al., 2012) . Specifically, certain epigenetic processes can either enhance or repress individual genes or clusters of genes that are responsible for healthy functioning (Adalsteinsson & Ferguson-Smith, 2014) . One manner in which epigenetic processes influence gene expression is through genomic imprinting, which refers to the process by which only one allele is expressed in a parental origin specific manner (i.e., only the paternal or maternal allele is expressed in the offspring). This epigenetic "tag" on imprinted genes can silence a gene variant and often is resistant to change, making it a viable candidate for understanding how DNA is modified and contributes to changes in gene expression. There are several epigenetic mechanisms that can modify chromatin (DNA and protein complex) and subsequent gene expression, such as histone (Adalsteinsson & Ferguson-Smith, 2014) , 5-hydroxymethylcytosine (5hmC) or 5-carboxylcytosine (5caC) modifications (Shi, Ali, Tang, & Yang, 2017) , to name a few. However, the most commonly studied epigenetic mechanism is cytosine methylation, in part due to its relative ease in measurement.
Cytosine methylation (herein referred to as DNAm) refers to the binding of a methyl group (CH 3 ) to a cytosine in the context of a C─G dinucleotide (i.e., CpG site). CpG sites often are non-randomly distributed and methylated across the genome, but may cluster forming CpG islands that stretch approximately 1,000 base pairs on or around promoter regions of a gene. CpG islands are highly conserved and enriched near gene promoters in mostly an unmethylated state, and may serve to regulate gene expression (Lim & Maher, 2010) . For example, several genome-wide studies have found significant correlations between methylated CpG islands and reduced gene expression, even though methylation of CpG islands in promoter regions was rare (e.g., Ball et al., 2009; Deng et al., 2009) 
| DNA methylation and fetal HPA axis functioning
Understanding the influence of stress on the maternal HPA axis during pregnancy is important because it can have an effect on the fetal HPA axis and overall development of the fetus (Graignic-Philippe et al., 2014) . Briefly, the HPA axis is a neuroendocrine system comprised of the hypothalamus, pituitary gland, and adrenal glands; all three interact with one another to regulate the body's response to stress, but also regulate other processes, such as digestion and immune functioning.
When an individual is exposed to stress, the HPA axis is activated by the release of corticotropin-releasing hormone (CRH) from the hypothalamus; this activates the release of adrenocorticotropic hormone (ACTH) by the pituitary gland, which then activates the release of glucocorticoids (i.e., cortisol) from the adrenal glands, allowing the individual to respond to stress via a "fight or flight" response (Oakley & Cidlowski, 2013) . The release of cortisol also serves to suppress the production of additional CRH and ACTH, limiting the production of additional glucocorticoids (i.e., cortisol) and creating a negative feedback loop. When a mother is exposed to stress during pregnancy, the fetus is protected from excess cortisol exposure through various methods; however, prolonged stress exposure can impact the functioning of genes responsible for protecting the fetus, particularly those that have downstream effects on the fetal HPA axis.
To date, research has identified variable DNAm in several genes implicated in fetal HPA axis functioning; however, the majority of studies focus on NR3C1. This gene encodes for glucocorticoid receptor (GR) production, which aids in suppressing cortisol production, protecting the fetus from excess cortisol exposure and maintaining proper functioning of the HPA axis' negative feedback loop (Moisiadis & Matthews, 2014) . Although informative, many other genes have been suggested in fetal HPA axis functioning and provide a more complete picture of how DNAm can influence infant HPA axis functioning and subsequent outcomes beyond birth. For example, another gene evidenced to protect the fetus from excess cortisol exposure is 11β-HSD2, a placental gene that converts maternal cortisol into inert cortisone to protect the fetus from excess levels of maternal cortisol (Conradt, Lester, Appleton, Armstrong, & Marsit, 2013) .
Another gene, FKBP5, which codes for FK506 binding protein 5, also is implicated in HPA axis activation since this gene facilitates the termination of the stress response by regulating GR sensitivity; polymorphisms of this gene that encode for increased activation of FKBP5 have been associated with increased GR resistance and subsequent dysregulation of the negative feedback loop (Binder, 2009) . Two other genes, CRH and CRHBP also are implicated in human HPA axis functioning, as CRH stimulates the production of ACTH, which results in the production of cortisol, while CRHBP regulates the bioavailability of CRH. Lastly, the serotonin transporter gene, SLC6A4, has been implicated in HPA axis functioning (e.g., Fuller, 1990) , as has the oxytocin receptor gene, OXTR (e.g., Heinrichs & Domes, 2008) , but research on variable DNAm among these genes in infants in response to prenatal stress is scant. See Table 1 for a description of the protein coded by each gene and its relevance to HPA axis functioning.
| THE CURRENT STUDY
The association between maternal stress during pregnancy and fetal and infant development has been well documented (Graignic-Philippe et al., 2014) ; however, findings are inconsistent and the molecular mechanisms underlying this association are still under debate. Recent theory and empirical evidence suggest that epigenetic sources, specifically DNAm, may explain the link between maternal stress and alterations of fetal HPA axis functioning, ultimately leading to poor pre and postnatal outcomes (e.g., Ryan, Mansell, Fransquet, & Saffery, 2016) . Although the evidence linking maternal stress during pregnancy to alterations in fetal HPA axis functioning and postnatal outcomes is mixed, the emphasis on this system in the literature and increased focus on epigenetic mechanisms linking maternal stress to fetal HPA SOSNOWSKI ET AL. These results elucidate the utility of animal research in informing and supplementing human studies. However, a goal of the current review was to examine psychosocial stressors, including those perceived as stressful by the mother. This focus on perceived (sometimes modifiable) stressors has utility for informing prevention and intervention efforts. Given this focus, and that a review including the relevant animal literature has recently been conducted, we proceeded to include only studies with human samples in our review.
The current systematic review advances this literature in several ways. First, examining DNAm and associated infant outcomes only during the first year of life provides a focused picture of the effects of DNAm, and avoids confounding the hypothesized associations by other factors (e.g., childhood maltreatment). Second, the examination of commonly studied HPA axis candidate genes promises to clarify the growing literature on candidate genes with functional relevance to developmental researchers. Lastly, the creation and application of a study quality review tool provides a standardized critique of current studies to reveal patterns within studies of varying quality.
| METHODS

| Definition and measurement of prenatal stress
For the purpose of this review, maternal prenatal stress was defined as traumatic life events, stressful situations/experiences, subsequent perceptions of stressors, or the resulting phenotypes of stressors that a mother experienced during pregnancy. Examples of stressors included in the systematic search were: low socioeconomic status (SES), perceived stress, anxiety, depression, and war-related trauma (e.g., destruction of property, kidnapping). Although not always conceptualized as stressors, we included stress-related phenotypes (e.g., anxiety, depression) in our definition of maternal prenatal stress, primarily because of their common conceptualization as unique stressors within the field (15 of 23 studies in the review included measures of mental health as maternal prenatal stressors).
| Definition and measurement of infant DNAm
Studies included in the current review measure DNAm within the NR3C1, FKBP5, 11β-HSD2, CRH, CRHBP, SLC6A4, and OXTR genes in infants (i.e., < 12 months old). Genes were selected based on their frequent inclusion within the developmental literature examining maternal prenatal stress and DNAm, as well as their involvement with HPA axis functioning and overall stress reactivity in humans in response to early life stress (see Table 1 ). Measurement of DNAm was 11β-HSD2 is expressed in the placenta and serves to protect the fetus from excess cortisol exposure, which can lead to dysregulation of the fetal HPA axis.
FKBP5 FK506 Binding Protein 5
This gene encodes for a protein relevant for immunoregulation and other cellular processes requiring protein folding and trafficking.
FKBP5 aids in HPA axis regulation by terminating the stress response through determining sensitivity to glucocorticoid receptors.
CRH Corticotropin Releasing Hormone
This gene encodes for a protein that aids in the generation of the peptide hormone, corticotropin.
CRH aids in synthesizing adrenocorticotropic hormone (ACTH), which stimulates the production and release of cortisol by the pituitary gland, as part of the HPA axis.
CRHBP Corticotropin Releasing Hormone Binding Protein
This gene encodes for a protein that aids in the synthesis of CRH.
CRHBP regulates the availability of CRH at its relevant receptors.
SLC6A4
Solute Carrier Family 6, Member 4
This gene encodes for a protein that is integral in the transmission of serotonin from synaptic spaces into presynaptic neurons.
Decreased production of serotonin via SLC6A4 has been implicated in alterations of serotonergic modulation of the HPA axis (Fuller, 1990) .
OXTR Oxytocin Receptor
This gene encodes for a protein that acts as a receptor for oxytocin.
OXTR has been implicated in the regulation of the HPA axis in humans by suppressing the production of cortisol and ACTH (Heinrichs & Domes, 2008) .
limited to infancy in order to control for additional postnatal factors that could influence DNAm patterns in newborns.
| Search strategy
An online search for this review was carried out through the PubMed, were conducted by scanning the reference list of each article retained (N = 23). Six articles were identified through these hand searches.
| Study selection
Studies included in the current review must have been published in a peer-reviewed journal, written in English, included a human sample, and reported clear methodology for measuring DNAm. In addition, studies examining DNAm beyond infancy (i.e., 12 months after birth) were excluded in order to limit additional factors that could contribute to DNAm above and beyond prenatal sources. Study selection was limited to samples including humans since the inclusion of animal studies was outside the scope of our review. Lastly, a meta-analysis of the relevant literature was not completed for two primary reasons: 1) DNAm was quantified differently across studies (e.g., percent methylation vs. full/no methylation), and 2) the measurement of CpG sites within genes examined in each study was not consistent, making comparisons across studies difficult. Taking these factors into account, a qualitative review provides an efficient review of the literature, and effect sizes are reported when available.
| Study quality review tool
Because there is no accepted, standardized tool for assessing DNAm study quality, a study-quality tool was created to assess each of the studies based on criteria specified by the authors of this review. The tool was developed based on key factors that impact study results and implications. All criteria were generated by the first author and approved by co-authors. As summarized in Table 2 , the six criteria used to assess study quality were: sample size, timing of measurement of prenatal stress, methods of measurement of prenatal stress and DNAm, study design, and inclusion of covariates. Ratings for all study criteria were on a scale of 0-1 for being absent or present.
According to Tsai and Bell (2015) , epigenome-wide association studies (EWAS) utilizing case-control and disease-discordant monozygotic twin designs find modest to moderate effect sizes of 0.13-6.6% difference in DNAm levels between affected and unaffected individuals. In their own simulations, the authors found that sufficient power (i.e., >80%) to detect 6% difference in methylation within a case-control design (a common design among studies in our review) at nominal significance (i.e., p = .05) requires 100 individuals. At the genome-wide level of significance, (i.e., p < 10
) at least 422 individuals are required to detect a mean difference of 7%. Based on these simulations, we used a cut-off 100 as a sufficient sample size for case-control or correlational studies, and 422 for epigenome-wide studies.
Since it is best practice to collect data using multiple raters and/or methods, and a goal of our review was to assess the effects of stress during specific trimesters of pregnancy, these were the two evaluative criteria for the measurement of prenatal stress. The use of multiple raters (e.g., clinical assessment and self-report) and measurement during multiple trimesters received a rating of 1, while the use of only self-reports, or only retrospective reports of stress at a single time 
1) Sample size
Case-Control/Correlational Studies: n < 100 were rated as 0 and n ≥ 100 were rated as 1. Epigenome-wide studies: n < 422 were rated as 0, n ≥ 422 were rated as 1
2) Timing of measurement of stressor(s)
Prospective reports (i.e., ratings during multiple trimesters) were rated as 1 and retrospective reports (i.e., data collected at a single time point) were rated as 0.
3) Methods for measuring stressor(s)
Studies using multiple raters (e.g., clinician-rated and self-rated) were coded as 1 and studies using only self-report were coded as 0.
4) Measurement of DNA methylation
Clear statements of methodology (e.g., assay method, use of quality control measures, accounting for batch effects) were rated as 1 and unclear statements of methodology were rated as 0.
5) Study design
Cross-sectional research designs utilizing a control group were rated as 1, and cross-sectional designs without a control group were rated as 0.
6) Covariates
Inclusion of key covariates (e.g., birth weight, tissue type, gestational age at birth)-or exclusion of participants based on these criteria-was rated as 1, and no inclusion of covariates was rated as 0.
Quality ratings range on a scale from 0 to 6, with higher scores indicating higher study quality.
point received a rating of 0. DNAm measurement quality was assessed on whether or not a clear report of methodology for collecting DNA and measuring DNAm patterns was present. For the purposes of this review, a clear report of methodology consists of information on the assay method and software used to process DNAm, and any use of quality controls to ensure accuracy of DNAm analyses. Next, crosssectional studies with a negative control group received a rating of 1 due to their ability to aid in inferring causality, while correlational studies with no control group received a rating of 0. Lastly, studies including major covariates (e.g., gestational age at birth, birth weight)-or excluding participants based on these criteria-were given a rating of 1, while studies that did not include covariates received a rating of 0.
The possible range of ratings was 0-6, with higher scores indicating a higher study quality.
| RESULTS
The PRISMA (Moher, 2009) In total, 23 articles were included in the current systematic review. 
| Study quality ratings
Study quality ratings are presented in Table 3 . Two independent researchers provided quality ratings for each article and conferred to discuss any discrepancies, and a third party was used (if necessary) to solve any discrepancies. No third party was needed to resolve qualityrating discrepancies. Quality ratings for studies included in the review ranged from 2 to 6 (Median = 3). Quality ratings tended to be diminished by study design (e.g., cross-sectional with no negative control group), using only self-reports of stressors, and/or utilizing a small sample size. No other trends were identified within the quality ratings.
| Epigenome-wide analyses
Although the primary focus of our review was to examine DNAm of relevant candidate genes associated with maternal prenatal stress, our search also elicited relevant epigenome-wide studies; these studies have the advantage of taking an agnostic approach to examining the effects of maternal prenatal stress on infant DNAm, and are more appropriate for characterizing the broad impact of DNAm on HPA axis functioning, as evidenced by the candidate gene literature elsewhere (for a discussion on this topic, see Dick et al., 2015) . In the current review, our search elicited four studies that contained epigenome-wide analyses of the association between maternal prenatal stress and infant DNAm. Non, Binder, Kubzansky, and Michels (2014) examined approximately 450,00
CpG sites across the infant epigenome and identified methylation of 42 CpG sites that differed significantly between mothers who had experienced prenatal depression or had used SSRI medications and controls. A majority of these sites (33 of 42) revealed decreased levels of DNAm. After using a stricter criterion to account for false discovery, 10 CpG sites remained significant, ranging from 9% decreased methylation to approximately 4% increased methylation in mothers exposed to prenatal depression compared to controls.
None of these significant CpG sites were located within HPA axisrelevant genes. Another study of over 27,000 CpG sites conducted by Schroeder et al. (2012) among 180 infants whose mothers were exposed to a variety of prenatal stressors (e.g., perceived stress, socioeconomic stress), finding 3,405 genes significantly associated with prenatal stress.
However, none of these included genes in the current review.
Although these studies have clear advantages over the candidate gene approach, the limited sample sizes decrease confidence in the ability to Sample sizes refer to the number of infants for which DNA samples were collected. Quality ratings range on a scale from 0 to 6, with higher scores indicating higher study quality. EWAS, epigenome-wide association study; LINE-1, long interspersed nucleotide elements. PCR, polymerase chain reaction; MeDIP, methylation DNA immunoprecipitation.
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| 133 detect significant effects. Furthermore, Non et al. (2014) studied mothers who were currently prescribed SSRI medication, and evidence suggests that SSRI medication can uniquely impact global methylation patterns (e.g., Menke & Binder, 2014) , so these results should be interpreted with caution. With these caveats in mind and the disparity in findings between epigenome-wide and candidate gene analyses, further use of the epigenome-wide approach will clarify the association between maternal prenatal stressors and infant DNAm.
| NR3C1
The twelve studies assessing NR3C1 methylation all examined exon 1 F ;
one study also examined exons 1 B and 1 D (Hompes et al., 2013) Similar to other findings, Monk et al. (2016) found that higher perceived maternal prenatal stress was associated with greater methylation of NR3C1 in infants. In addition, Braithwaite, Kundakovic, Ramchandani, Murphy, and Champagne (2015) found a sex-specific effect of maternal depressive symptoms on NR3C1 methylation, such that increases in mean methylation levels across 10 CpG sites were significant only for male offspring. Lastly, three studies failed to find significant correlations between maternal prenatal stressors and infant NR3C1 methylation Mansell et al., 2016; Ostlund et al., 2016) ; however, Ostlund et al. did observe a trend-level effect (p = .057) among females, such that infants whose mothers were exposed to a stressful life event during pregnancy had higher levels of DNAm compared to infants whose mothers did not. In sum, the majority of studies suggest that prenatal stress-both severe and common-is associated with hypermethylation of NR3C1 in newborns.
| 11β-HSD2
Six studies examined the effects of maternal prenatal stress on infant methylation of 11β-HSD2 across 13 CpG sites, with mixed findings. Conradt et al. (2013) found positive associations between selfreported maternal anxiety and infant DNAm at CpG site 4, and this association remained after controlling for self-reported maternal depression. Another study by Monk et al. (2016) found that higher levels of maternal perceived stress throughout pregnancy (e.g., feeling upset, feeling overwhelmed) was positively associated with infant DNAm. In contrast, Appleton et al. (2013) found that low maternal education was associated with an 8.8% decrease in methylation of 11β-HSD2 after controlling for covariates. Further, male infants possessed significantly lower 11β-HSD2 methylation levels compared to female infants when exposed to lower maternal education, increased poverty, and increased maternal socioeconomic risk. Marsit et al. (2012) , however, found no significant association between maternal prenatal SES (i.e., insurance status) and infant DNAm. Two other studies also failed to demonstrate a significant association between maternal prenatal anxiety and infant methylation of 11β-HSD2 across the same four CpG sites Stroud et al., 2016) . Overall, the evidence suggests an equivocal association between maternal prenatal stress and infant 11β-HSD2 methylation.
| OXTR
There is limited, mixed evidence regarding maternal prenatal stress and OXTR methylation. Cecil et al. (2014) found that increases in prenatal maternal risks (e.g., illness, interpersonal violence) were associated with increased infant DNAm within a CpG island of OXTR at birth.
Notably, this CpG island was found to be associated with gene transcription in previous studies (e.g., Kusui et al., 2001) . Conversely, Unternaehrer et al. (2016) found that increases in prenatal depression and general life stress were associated with decreases in infant OXTR methylation. Lastly, Rijlaarsdam et al. (2016) found no associations between prenatal cumulative stressors (e.g., illness, interpersonal stressors, financial difficulty) and OXTR methylation in infants. Given the equivocal findings, no conclusions can be drawn regarding prenatal stress and infant OXTR methylation.
| SLC6A4
Similar to OXTR, the evidence linking prenatal stress and SLC6A4 methylation in infants is limited. Devlin, Brain, Austin, & Oberlander (2010) found that 2nd trimester maternal depressive symptoms were inversely associated with infant methylation levels at two CpG sites.
However, Dukal et al. (2015) found no significant associations between several types of prenatal stress (i.e., depression, anxiety, SES, perceived stress, and psychosocial stress) and infant SLC6A4 methylation patterns across four CpG sites. To date, the findings provide no conclusive evidence that maternal prenatal stress is associated with variable infant SLC6A4 methylation.
| CRH, CRHBP, and FKBP5
The only study to examine maternal prenatal stress and infant methylation of the CRH and CRHBP genes found that war trauma was associated with increased CRH methylation at two (cg03405789, cg15971888) of 13 CpG sites examined. In addition, no association between prenatal stress and CRHBP methylation was detected.
According to Kertes et al. (2016) , the combined stressors (i.e., war and common) accounted for 31% of the variance in methylation at one CpG site (cg15971888), and 34% of the variance in methylation at the other site (cg03405789). Regarding FKBP5, Kertes et al. (2016) found positive associations between war-related and chronic stressors, and infant FKBP5 methylation at one CpG site (cg03546163). Monk et al. (2016) found similar results, with greater prenatal anxiety and depression being positively associated with infant FKBP5 methylation.
Overall, the evidence linking prenatal stress and methylation of these genes is limited, but given the significant findings, further examination of each gene is warranted.
| Postnatal HPA axis functioning
Four of the 22 studies included in the review also investigated associations between infant DNAm and infant HPA axis functioning.
Two studies investigated the relationship between infant NR3C1 methylation and infant cortisol reactivity. Specifically, Oberlander et al. (2008) found that increased NR3C1 methylation at CpG site three predicted an increased infant cortisol stress response at three months.
Another study by Conradt et al. (2016) found no relation between infant DNAm and basal cortisol levels at four months; however, greater methylation of NRC31 CpG site one was associated with lower cortisol levels for the first and second post-stress samples. Lastly, Ostlund et al. (2016) examined associations between infant NR3C1 methylation and fearfulness at age five months. Results revealed a significant association between DNAm and infant fearfulness, but only for females.
One study examined the association between infant methylation of 11β-HSD2 and infant stress reactivity (Stroud et al., 2016) . Stroud et al. (2016) found an indirect effect of infant methylation of 11β-HSD2
on baseline cortisol at one month. Specifically, methylation of 11β-HSD2 mediated the association between maternal prenatal major depressive disorder (MDD) and infant baseline cortisol such that a 1% decrease in methylation of 11β-HSD2 predicted a 9% increase in baseline cortisol levels of infants whose mothers had prenatal MDD. In addition, daughters of mothers with prenatal MDD had 51% higher baseline cortisol levels and 64% higher cortisol levels after exposure to a stressor compared to daughters of mothers without prenatal MDD.
Lastly, daughters of mothers with prenatal MDD had 75% higher cortisol levels after stress exposure compared to daughters of mothers who had experienced MDD only prior to conception. In sum, the studies examining infant DNAm and postnatal stress reactivity suggest that infant DNAm of the genes NR3C1 and 11β-HSD2 at birth may predict non-normative HPA axis functioning throughout infancy.
Further examination of this association among all genes included in the current review is warranted.
| DISCUSSION
The current systematic review yielded several findings that advance our understanding of the association between maternal prenatal stress, infant DNAm, and subsequent changes in infant HPA axis development.
Further, the unique design of the review provides additional information that strengthens our interpretation of findings within the literature. The use of a study quality review tool is an innovative component that allowed us to provide a critique of individual study methodology, and identify patterns across studies. For example, many studies likely did not have adequate power given the sample size and number of tests conducted with the data, limiting the ability to detect significant effects that may have been present. Understanding which factors contribute to a lower quality rating (e.g., limited sample size) can aid in identifying key factors that may contribute to null findings. Additional advantages of the current review were the examination of multiple candidate genes associated with HPA axis functioning, and epigenome-wide analyses. These approaches provide a more complete picture of infant DNAm. This is necessary because no single gene is solely affected by stress and acts alone to contribute to such complex alterations in HPA axis functioning. Rather, multiple genes may be affected and act simultaneously to influence HPA axis functioning and subsequent infant outcomes. Lastly, the examination of outcomes only during the first year of life limit factors that confound the associations examined in the review.
Given the unique approach of the current review, several broad findings are notable. First, NR3C1 was most commonly studied within the literature, and the strongest associations were detected within these studies. In regard to specific stressors, more severe stressors (e.g., war trauma) had the strongest association with infant DNAm, while stress-response phenotypes (e.g., depression) often were only modestly associated with infant DNAm. Although useful, the examination of more "true" stressors (e.g., interpersonal violence), rather than the phenotypes associated with stressors, may reveal different findings. That is, it is unclear whether the stress-response phenotypes or the stressor(s) that induce these phenotypes is driving epigenetic modification of the genome. Lastly, the inclusion of epigenome-wide studies brought to light the issue of replication within epigenetic research and the need for agnostic, large-scale studies that can detect small effects and clarify the role of DNAm in maternal prenatal stress and infant HPA axis functioning. Implications of the candidate gene and epigenome-wide studies are discussed below.
The most prominent findings from the review involve NR3C1, a gene implicated in GR production that helps to regulate the stress response. Across the 12 studies examining this gene, nine detected a significant association between maternal prenatal stressors and infant DNAm. Severe stressors (i.e., war stress) accounted for more variance in infant DNAm (35%) compared to less severe stressors (i.e., anxiety, SOSNOWSKI ET AL.
| 135 depression; 10%), and maternal stress during the 2nd and 3rd trimesters was most often associated with infant DNAm. Although there was no evidence of 1st trimester maternal stress influencing infant DNAm, research suggests that the fetal HPA axis does not typically mount a full stress response until about 20 weeks gestation (Moisiadis & Matthews, 2014) , so these findings align with our understanding of typical fetal development. Another important finding from the literature examining NR3C1 was the hypermethylation of CpG sites within transcription factor binding (TFB)
sites across several studies (Hompes et al., 2013; Kertes et al., 2016; Oberlander et al., 2008) . Although cytosine methylation does not need to occur within these sites to affect gene expression, DNAm of
CpG islands within these regions may be more likely to influence gene expression. Lastly, one study did detect sex differences in DNAm, with males exposed to maternal depressive symptoms during pregnancy having higher levels of DNAm across 10 CpG sites compared to females. Although no other studies detected sex differences in NR3C1 methylation, there is evidence suggesting that males are generally more susceptible to prenatal adversity (for review, see Bronson & Bale, 2015) . For example, evidence suggests that pregnant mothers of males have higher levels of cortisol compared to mothers of females, particularly during the 3rd
trimester (DiPietro, Costigan, Kivlighan, Chen, & Laudenslager, 2014) . It is possible that these variations in exposure to cortisol could contribute to marked differences in DNAm between males and
females. An avenue for future research could be to examine mean cortisol levels throughout pregnancy among male and female fetuses to begin to elucidate the factors influencing variations in DNAm between males and females.
Evidence linking maternal prenatal stress to DNAm of other genes in the current review was limited, with mixed findings. For example, two studies found positive associations between maternal depressive symptoms and general perceived stress and infant methylation of 11β-HSD2; however, Appleton et al. (2013) found an inverse association between low SES (i.e., maternal education) and methylation of 11β-HSD2, and three other studies found no significant association. Given that the human literature on 11β-HSD2 is small, it is possible that there are other CpG sites not examined that are more susceptible to methylation in the presence of prenatal adversity. Alternatively, the stressors examined may not be relevant to methylation of 11β-HSD2.
For example, research with a similar placental gene, NR3C1, found more severe stressors to be strongly associated with infant DNAm.
Given that only maternal depressive symptoms and SES were measured, it is possible that more severe social stressors (e.g., domestic or community violence) are associated with methylation of
11β-HSD2.
Regarding other novel genes associated with HPA axis functioning, one study examined the association between maternal prenatal adversity and methylation of CRH and CRHBP, genes associated with protein and/or cortisol production in HPA axis functioning. Kertes et al. (2016) revealed that war trauma was associated with methylation of CRH across two CpG sites in infants. Further, war-related stress accounted for over 30% of the variation in infant DNAm. Similar results were found for FKBP5, with Monk et al. (2016) another finding an inverse association, and another finding no association. Given these equivocal results, it may not be fruitful to examine genes more tangentially associated with HPA axis activation, instead focusing on directly relevant genes.
| EWAS findings
Four studies examined associations between prenatal stressors and infant DNAm across the entire genome. Non et al. (2014) examined over 480,000 genes and found both hyper-methylation and hypo-methylation at CpG sites unrelated to HPA axis functioning. Another study by Nieratschker et al. (2014) found an association between maternal prenatal stress and infant DNAm, but none of the genes were those included in our review. Lastly, Schroeder et al. (2012) and Rodney and Mulligan (2014) found no relation between prenatal stressors and infant DNAm in similarly large analyses. Genome-wide studies are agnostic, preventing researchers from having a limited scope of epigenetic "tags" across the genome. However, EWAS analyses require disproportionately large sample sizes (often hundreds, if not thousands of individuals) in order to identify significant variations in DNAm on a genome-wide scale (Tsai & Bell, 2015) . All epigenome-wide studies included in the current review were underpowered to detect small effects, which are common in the literature, due to sample sizes that ranged from 24 (Rodney & Mulligan, 2014) to 201 participants (Schroeder et al., 2012) .
Although effect sizes are typically larger in epigenome-wide studies and require slightly smaller samples compared to genome-wide studies, the pattern of findings in our review is not unexpected. For example, individual candidate gene studies within psychiatric genetics research have detected significant effects, but when examined at the genomewide level, replication has been scarce (e.g., Neale et al., 2010) .
Nonetheless, future EWAS with appropriate sample sizes will provide greater insight into the relation between prenatal stressors and infant DNAm across the epigenome.
| Postnatal HPA axis functioning
Four studies in the current review examined the association between infant DNAm of NRC31 and 11β-HSD2, and postnatal HPA axis functioning. Both Oberlander et al. (2008) and Conradt et al. (2016) found associations between NRC31 methylation and abnormal cortisol functioning. These findings support the view of NRC31 methylation as a vehicle through which prenatal stress adversely impacts offspring HPA axis functioning, and these changes may increase susceptibility to psychopathology (Moisiadis & Matthews, 2014) of what constitutes a stressor is another limitation plaguing the field. As noted by Kagan (2016) , there should be a concerted effort to specify what constitutes a stressor in terms of its impact on specific biological and health outcomes. We chose to define stress in broad terms as to capture all types of stress as defined by the relevant literature.
Moreover, our qualitative review should serve to inform in what specific contexts certain experiences deemed as stressful by the mother constitute noticeable epigenetic alterations that have measureable physiological and behavioral consequences for infants. It is our hope that this review will inform future studies in considering a broader range of well-defined stressors to accurately capture which maternal prenatal stressors significantly affect methylation patterns in infants.
Another limitation of the current literature is the lack of assessment of relevant covariates. Several studies excluded participants on certain criteria, but did not include covariates in their analyses, and five studies did not include quality control measures (such as batch effects) during DNAm analyses. Exclusion of this information can bias findings and subsequent interpretations of relations between these variables.
Furthermore, the majority of studies (15 out of 23) drew data from largely Caucasian, high SES samples; this ethnic and socioeconomic homogeneity may limit the generalizability of findings. Sample size also was an issue across studies, with many having an insufficient number of observations to have adequate power to detect all possible significant effects. Lastly, DNAm can only be measured using peripheral measures (e.g., saliva samples) even though these processes are primarily occurring in the brain. This limitation should be noted in all empirical studies of DNAm involving humans, and examination of tissue-specific and developmentally specific effects should be carried out to elucidate findings (e.g., Kertes et al., 2016) .
| Limitations of the current review
The current review has several limitations. First, no theses, dissertations, or unpublished studies were screened during the article selection process. These studies could have yielded relevant information;
however, best practice dictates that only studies that have been subject to peer review should be included due to the need for study quality standards. Further, we limited the review to HPA axis relevant genes that are most commonly examined within the developmental literature. Inclusion of other genes that influence HPA axis functioning -or stress reactivity more broadly-would help to provide a more complete representation of the association among maternal prenatal stress, infant DNAm, and infant HPA axis functioning. Similarly, we only examined one system (HPA axis) that can become dysregualted in response to maternal stress and affect fetal and infant development. Beijers et al. (2014) have noted several limitations to examining this system, such as the weak associations between self-reports of stress and measures of HPA axis functioning. Although a review of the relevant literature on epigenetic processes affecting this system is warranted, other relevant systems (e.g., immune system, intestinal microbiota) and their associated genes should be explored to further our understanding of the wide-reaching effects of maternal prenatal stress on the fetus. Lastly, it is possible that our search strategy (e.g., selected terms) prevented us from capturing studies that examined the association between maternal prenatal stress and infant DNAm as a sub-finding, as this information would not have appeared in the title or abstract when we first screened studies for inclusion.
| CONCLUSION
The current review provides an overview of evidence that supports the links among maternal prenatal stress, infant DNAm, and infant HPA axis functioning. Although the most prevalent findings were for | 137 epigenome, as some research has found that some stress-related phenotypes (e.g., posttraumatic stress disorder) are associated with hypo-methylation of the epigenome (for review, see Palma-Gudiel et al., 2015) . Lastly, the use of a study quality review tool provides a more critical examination of DNAm studies and elucidates the strengths and weaknesses of current research. In sum, the current systematic review advances our understanding of the links among prenatal stress, infant DNAm, and HPA axis functioning, and provides a path for future studies examining these associations.
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